Expansion Growth Rochester Clinical Research has recently opened a new Buffalo, New York location in March 2024, signaling active regional expansion and potential for increased multi-site trial management, site network collaboration, and shared referrals.

Awards & Reputation Recognized as best Clinical Trial Site company at the 2023 World Vaccine Congress awards, highlighting strong industry credibility to attract sponsors looking for high-quality execution and reliable site performance.

Full-Service Capabilities Operates as a full-service phase I-IV outpatient research facility with pre-screening strengths and rapid timelines, suggesting opportunities to pitch broad trial portfolios and faster study start-up for sponsors seeking turnkey site partnerships.

Vaccine & Infectious Disease Focus Historical involvement in vaccine studies and infectious disease research (including E. coli infection vaccine efforts) indicates alignment with sponsor programs in vaccines, infectious diseases, and preventative medicine areas.

Digital & Data Readiness Tech stack including Google Cloud, analytics and tracking tools, and data accuracy emphasis suggest readiness for data-driven trials, remote monitoring, and robust data capture to meet sponsor expectations for quality and compliance.